about
Pilot study to evaluate feasibility of image-guided breast-conserving therapy in the advanced multimodal image-guided operating (AMIGO) suiteIdentification of molecular markers for metastasis-related genes in primary breast cancer cells.F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous mannerIntratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.A low cost training phantom model for radio-guided localization techniques in occult breast lesions.The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients.Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the BreastEfficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trial.Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.Modern Trends in the Surgical Management of Paget's Disease.The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy.Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery.The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.Team approach to providing the multidisciplinary medical treatment derived by the patients and their familyStudy on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of JapanUnderstanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer centerIncidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapyReply to K. Lin et alEffectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03
P50
Q27339561-A6C83530-09B0-4780-8790-AEEB37353879Q33222611-863E6DA3-BEAC-41C4-89CB-29E8DDB82482Q35056718-8E4D6F2C-2E9C-40FB-960E-8A4F482C2271Q35713540-9C92F407-7071-49D3-B8E0-FECC7AA9CBB0Q36093843-A96A7742-FFB0-42CC-B7D3-B9816B5DDEF3Q36288379-8CCB18BE-EAD9-42E1-A4AC-D77D1314272BQ36711189-62670E6F-547D-4088-80BA-A729055B9406Q36858456-07B12662-3978-4FC6-BF60-2D44D0A7AC77Q36915217-7AEB5E9A-C64A-4367-82AC-E96815ABCF81Q37641066-515AE904-81A3-4CB7-ACFC-87D197D86E11Q38399495-15390BFC-EAED-4F9D-B0BA-F4C2303CE196Q38464311-07C70B0D-AE18-4C64-B87C-F0D1B5871F22Q38641730-079BC248-BBB7-4C04-88D5-D6AD6594B536Q38974396-F9124E95-27BE-449B-B65E-1BB92A27EA66Q40325984-8D0F5C79-2CAB-45D1-A434-15008A874A13Q40705890-45CB9976-0F1B-4A35-8248-C97FEEBBB091Q41352543-F1B60346-FD0E-4210-BBAD-936AEF2349A0Q41697616-8530B9D5-4965-453B-913D-BE751ED6B19DQ50045537-A1CDBA4D-F23C-4F6B-8102-285D8C6B14C0Q50227670-1D93B0F1-624E-46AB-9C63-037BC76CCD73Q50246934-ADA413E8-E15F-42E0-B5BA-D463B59838AFQ51606753-3336C54B-EDD7-4A64-B994-45740CEA99CBQ51749152-B799B66B-CB0C-4710-9942-2679E57CF2F3Q54162238-8F456966-4D9F-4281-AF11-D854C04790F8Q54324247-B9CEFF9A-E496-4837-852A-01C06166DCD1Q81290450-DA588A00-66AF-43C2-8B31-E6121B1E390CQ84675750-6A4FF0B8-0F76-46A2-BD08-8E9802E6C028Q85653841-7DC6B172-A310-4263-A273-EBC52D3EEA6BQ87426029-FCE7A838-FCEA-4A8A-9430-EFF9719A98B8Q88001809-34176EFB-E75F-435A-9292-532D670E0FF5Q89414851-4B5FA55F-334B-4958-8A9D-994D822627C4
P50
description
investigador
@es
researcher
@en
name
Yasuaki Sagara
@en
type
label
Yasuaki Sagara
@en
prefLabel
Yasuaki Sagara
@en
P31
P496
0000-0001-5705-1739